Cargando…
IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182216/ https://www.ncbi.nlm.nih.gov/pubmed/34158836 http://dx.doi.org/10.1177/17562864211022109 |
_version_ | 1783704161744846848 |
---|---|
author | Wienands, Jürgen |
author_facet | Wienands, Jürgen |
author_sort | Wienands, Jürgen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8182216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-81822162021-06-21 IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments Wienands, Jürgen Ther Adv Neurol Disord Editorial SAGE Publications 2021-06-03 /pmc/articles/PMC8182216/ /pubmed/34158836 http://dx.doi.org/10.1177/17562864211022109 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Editorial Wienands, Jürgen IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple sclerosis-modifying therapies to curtail lymphocyte compartments |
title | IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple
sclerosis-modifying therapies to curtail lymphocyte compartments |
title_full | IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple
sclerosis-modifying therapies to curtail lymphocyte compartments |
title_fullStr | IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple
sclerosis-modifying therapies to curtail lymphocyte compartments |
title_full_unstemmed | IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple
sclerosis-modifying therapies to curtail lymphocyte compartments |
title_short | IgG antibody titers to SARS-CoV-2 reveal a distinct efficacy of multiple
sclerosis-modifying therapies to curtail lymphocyte compartments |
title_sort | igg antibody titers to sars-cov-2 reveal a distinct efficacy of multiple
sclerosis-modifying therapies to curtail lymphocyte compartments |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182216/ https://www.ncbi.nlm.nih.gov/pubmed/34158836 http://dx.doi.org/10.1177/17562864211022109 |
work_keys_str_mv | AT wienandsjurgen iggantibodytiterstosarscov2revealadistinctefficacyofmultiplesclerosismodifyingtherapiestocurtaillymphocytecompartments |